Glycotope Doses First Patients in Phase IIb Study with PankoMab-GEX(TM) for the Maintenance Therapy of Ovarian Carcinoma

Source :: Thomson Reuters ONE. November 25, 2013
Publication Year :: 2013
Abstract: (Thomson Reuters ONE via COMTEX) -- Glycotope GmbH / Glycotope Doses First Patients in Phase IIb Study with PankoMab-GEX(TM) for the Maintenance Therapy of Ovarian Carcinoma . Processed and transmitted [...]

Subjects :: Thomson Reuters Corp. -- Product development
Medical research
Medicine, Experimental
Antineoplastic agents -- Product development
Antigenic determinants
Information services industry -- Product development
Carcinoma -- Care and treatment
Cancer -- Care and treatment
Clinical trials
Information services -- Product development
Antimitotic agents -- Product development
Information services industry
Business, international

Tools